IFITM proteins - cellular inhibitors of viral entry

被引：101

作者：

Smith, S. E. ^{[1
]}

Weston, S. ^{[2
]}

Kellam, P. ^{[1
,3
]}

Marsh, M. ^{[2
]}

机构：

[1] Wellcome Trust Sanger Inst, Hinxton CB10 1SA, England

[2] UCL, MRC Lab Mol Cell Biol, London WC1E 6BT, England

[3] UCL, Div Infect & Immun, MRC UCL Ctr Med Mol Virol, London WC1E 6BT, England

来源：

CURRENT OPINION IN VIROLOGY | 2014年 / 4卷

基金：

英国生物技术与生命科学研究理事会; 英国医学研究理事会; 英国惠康基金;

关键词：

INDUCED TRANSMEMBRANE PROTEIN-3; ANTIVIRAL ACTIVITY; S-PALMITOYLATION; HIV-1; INFECTION; VIRUS; RESTRICTS; GENE; RESISTANCE; TETHERIN; FAMILY;

D O I：

10.1016/j.coviro.2013.11.004

中图分类号：

Q93 [微生物学];

学科分类号：

071005 ; 100705 ;

摘要：

Interferon inducible transmembrane (IFITM) proteins are a recently discovered family of cellular anti-viral proteins that restrict the replication of a number of enveloped and non-enveloped viruses. IFITM proteins are located in the plasma membrane and endosomal membranes, the main portals of entry for many viruses. Biochemical and membrane fusion studies suggest IFITM proteins have the ability to inhibit viral entry, possibly by modulating the fluidity of cellular membranes. Here we discuss the IFITM proteins, recent work on their mode of action, and future directions for research.

引用

页码：71 / 77

页数：7

共 50 条

[41] Viral versus cellular BCL-2 proteins
Hardwick, JM
Bellows, DS
CELL DEATH AND DIFFERENTIATION, 2003, 10 (Suppl 1) : S68 - S76
[42] IFITM Proteins Inhibit Entry Driven by the MERS-Coronavirus Spike Protein: Evidence for Cholesterol-Independent Mechanisms
Wrensch, Florian
Winkler, Michael
Poehlmann, Stefan
VIRUSES-BASEL, 2014, 6 (09): : 3683 - 3698
[43] Different kinetics of viral replication and DNA integration in the main HIV-1 cellular reservoirs in the presence and absence of integrase inhibitors
Surdo, Matteo
Cortese, Maria Francesca
Orlandi, Chiara
Di Santo, Fabiola
Aquaro, Stefano
Magnani, Mauro
Perno, Carlo Federico
Casabianca, Anna
Ceccherini-Silberstein, Francesca
ANTIVIRAL RESEARCH, 2018, 160 : 165 - 174
[44] Characteristics of IFITM, the newly identified IFN-inducible anti-HIV-1 family proteins
Chutiwitoonchai, Nopporn
Hiyoshi, Masateru
Hiyoshi-Yoshidomi, Yuka
Hashimoto, Michihiro
Tokunaga, Kenzo
Suzu, Shinya
MICROBES AND INFECTION, 2013, 15 (04) : 280 - 290
[45] The Role of IFITM Proteins in Tick-Borne Encephalitis Virus Infection
Chmielewska, Alicja M.
Gomez-Herranz, Maria
Gach, Paulina
Nekulova, Marta
Bagnucka, Malgorzata A.
Lipinska, Andrea D.
Rychlowski, Michan
Hoffmann, Weronika
Krol, Ewelina
Vojtesek, Borivoj
Sloan, Richard D.
Bienkowska-Szewczyk, Krystyna
Hupp, Ted
Ball, Kathryn
JOURNAL OF VIROLOGY, 2022, 96 (01)
[46] Viral dependence on cellular ion channels - an emerging anti-viral target?
Hover, Samantha
Foster, Becky
Barr, John N.
Mankouri, Jamel
JOURNAL OF GENERAL VIROLOGY, 2017, 98 (03) : 345 - 351
[47] Interaction between viral proteins and hosts and its disturbance in the cellular responses to ionising radiation
Zhou, Ping-Kun
Sun, Yi
An, Jing
INTERNATIONAL JOURNAL OF RADIATION BIOLOGY, 2009, 85 (07) : 587 - 597
[48] A New Class of Hepatitis B and D Virus Entry Inhibitors, Proanthocyanidin and Its Analogs, That Directly Act on the Viral Large Surface Proteins
Tsukuda, Senko
Watashi, Koichi
Hojima, Taichi
Isogawa, Masanori
Iwamoto, Masashi
Omagari, Katsumi
Suzuki, Ryosuke
Aizaki, Hideki
Kojima, Soichi
Sugiyama, Masaya
Saito, Akiko
Tanaka, Yasuhito
Mizokami, Masashi
Sureau, Camille
Wakita, Takaji
HEPATOLOGY, 2017, 65 (04) : 1104 - 1116
[49] Inhibition of HIV-1 entry by antibodies: potential viral and cellular targets
Phogat, S.
Wyatt, R. T.
Hedestam, G. B. Karlsson
JOURNAL OF INTERNAL MEDICINE, 2007, 262 (01) : 26 - 43
[50] Hepatitis C Viral Entry Inhibitors Prolong Viral Suppression by Replication Inhibitors in Persistently-Infected Huh7 Cultures
Bush, Caroline O.
Greenstein, Andrew E.
Delaney, William E.
Beran, Rudolf K. F.
PLOS ONE, 2013, 8 (06):

← 1 2 3 4 5 →